Full-Time
Regional Technical Advisor
Updated on 9/4/2026
ChampionX
1,001-5,000 employees
Chemistry solutions, engineered equipment, digital oilfield.
No salary listed
No H1B Sponsorship
Pleasanton, TX, USA
In Person
The role is based in Pleasanton, Texas, with travel throughout the assigned sales territory and up to 10% overnight travel.
Bachelor's
 Solution Engineering (1) |
|---|
Get referred to ChampionX
See people who can refer or advise you
- A high school diploma, GED, or equivalent is required.
- At least 3 years of industry experience is required.
- A valid driver's license with an acceptable motor vehicle record is required.
- The candidate must be able to travel throughout the assigned sales territory and support up to 10% overnight travel.
- The candidate must be legally authorized to work in the United States.
- At least 3 years of experience in chemical applications, production chemicals, technical support, field operations, or a related industry is required.
- A strong chemical engineering foundation is required, including knowledge of chemical processes, fluid systems, reaction principles, and process design for upstream and midstream operators.
- Competency in corrosion, scale, and other predictive models is required.
- A strong understanding of production chemistry, chemical treatment programs, and process optimization is required.
- Familiarity with laboratory testing, product performance evaluations, and field trial execution is required.
- Understanding of corrosion management, scale control, emulsion treatment, flow assurance, asset integrity, or process improvement initiatives is required.
- The candidate must be able to evaluate operational challenges and recommend practical technical solutions.
- Strong troubleshooting and problem-solving skills are required, including the ability to identify root causes and implement corrective actions.
- Experience supporting customers in field, production, or industrial environments is required.
- The candidate must be able to communicate complex technical concepts to all levels of the customer organization.
- Strong customer service, relationship-building, and interpersonal skills are required.
- The candidate must be able to work collaboratively with sales, operations, laboratory, and technical teams.
- Strong organizational, time management, and project coordination skills are required.
- Proficiency with Microsoft Office Suite and business systems is required.
- The candidate must demonstrate commitment to safety, compliance, and customer satisfaction.
- Serve as the primary technical resource for customers and the commercial team by providing expertise on chemical products, treatment programs, and application recommendations.
- Partner with sales representatives to understand customer requirements and develop technically sound solutions aligned with operational and business objectives.
- Monitor treatment program performance and recommend adjustments to improve efficiency, reliability, and cost-effectiveness.
- Evaluate customer operations and technical challenges to identify opportunities for process improvement, performance optimization, and reliability enhancement through chemical treatment solutions.
- Provide technical consultation throughout the sales cycle, including opportunity assessment, solution development, proposal support, and post-implementation follow-up.
- Support business growth initiatives by identifying opportunities for expanded product utilization, treatment optimization, and value-added technical services within customer accounts.
- Analyze operational, laboratory, and field performance data to develop recommendations that improve treatment effectiveness, reduce operational risks, and enhance customer outcomes.
- Troubleshoot process and production issues, identify root causes, and recommend appropriate corrective actions.
- Support customer meetings, site visits, technical reviews, field trials, and product evaluations.
- Communicate complex technical concepts clearly and practically to technical and non-technical stakeholders.
- Deliver technical presentations and training sessions to customers and internal teams as needed.
- Develop and maintain strong customer relationships by serving as a trusted advisor and providing responsive technical support.
- Collaborate with laboratory, operations, engineering, product management, and other cross-functional teams to address customer needs and resolve technical challenges.
- Assist in preparing technical reports, proposals, treatment recommendations, performance summaries, and customer presentations.
- Maintain accurate documentation of customer interactions, technical evaluations, project activities, and solution recommendations.
- Stay informed about industry trends, emerging technologies, and competitive solutions to support customer needs and business growth.
- Conduct activities in compliance with company policies, customer requirements, and applicable health, safety, environmental, and regulatory standards.
- Promote a strong safety culture and support the safe application, handling, and use of chemical products in the field.
- A bachelor's degree in Chemical Engineering, Chemistry, Petroleum Engineering, or a related technical discipline is preferred.
- Experience supporting commercial sales teams in a technical, pre-sales, or applications engineering capacity is preferred.
- Knowledge of production chemicals, water treatment, process treatment, or specialty chemical applications is preferred.
- Experience analyzing operational data and translating findings into actionable customer recommendations is preferred.
- Experience preparing technical proposals, presentations, and customer-facing reports is preferred.
- Leadership and mentoring capabilities are preferred.
- The ability to conduct technical training sessions for customers and internal stakeholders is preferred.
- Knowledge of industry regulations, environmental requirements, and safe chemical handling practices is preferred.
- Experience using customer relationship management systems, business intelligence tools, and data visualization platforms is preferred.
- Strong project management capabilities, including the ability to manage multiple priorities and customer opportunities simultaneously, are preferred.
- The ability to influence customer decisions through technical expertise and consultative problem-solving is preferred.
- Experience supporting product development, commercialization, or application testing programs is preferred.
ChampionX offers chemistry solutions, engineered equipment, on-site services, and digital tools to support oil and gas operations from drilling to production. Its products include production chemicals like corrosion inhibitors and scale control agents, production and automation equipment such as artificial lift systems, drilling and completion technologies, and digital oilfield analytics to optimize performance. The company differentiates itself with an integrated, lifecycle-focused portfolio that combines chemistry, equipment, automation, drilling tech, and data insights for a range of customers. Its goal is to help clients produce energy safely and efficiently while reducing costs and environmental impact.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
The Woodlands, Texas
Founded
2017
Get referred to ChampionX
See people who can refer or advise you
Simplify's Take
What believers are saying
- SLB expects $400 million annual pretax synergies within three years.
- ChampionX products now cross-sell through SLB's global customer base and service network.
- Chemical, artificial-lift, and emissions offerings strengthen SLB's production recovery push in 2026.
What critics are saying
- ChampionX no longer exists independently; SLB absorbed the brand in July 2025.
- 2026 securities suits target April 2024 buybacks and management disclosures.
- Antitrust scrutiny forced divestitures, including US Synthetic, eroding standalone strategic value.
What makes ChampionX unique
- ChampionX became SLB's production and recovery platform on July 16, 2025.
- Its portfolio spans production chemicals, artificial lift, digital production, and emissions technologies.
- US Synthetic and Wellmark gave ChampionX niche subsurface and chemical-injection capabilities.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%CHX deadline: CHX investors with losses in excess of $100K have opportunity to lead ChampionX Corporation securities fraud lawsuit. * By THE ROSEN LAW FIRM, P. A. * 10 hrs ago * 0 NEW YORK, June 20, 2026 /PRNewswire/ - Why: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024 (the "Class Period"), of the important July 14, 2026 lead plaintiff deadline. So what: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: Ricentral encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share. To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
INVESTOR REMINDER: Berger Montague notifies ChampionX Corporation (CHX) investors of a class action lawsuit and deadline. Published on 06/17/2026 at 09:08 am EDT Newsfilecorp Philadelphia, Pennsylvania-(Newsfile Corp. - June 17, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against ChampionX Corporation (NASDAQ: CHX) ("ChampionX" or the "Company") on behalf of investors who sold ChampionX common stock during the period from February 29, 2024 through April 1, 2024 (the "Class Period"). Headquartered in The Woodlands, TX, ChampionX was a supplier of production chemicals and artificial lift solutions to oil and gas operators worldwide. It was acquired by SLB in July 2025. According to the lawsuit, while ChampionX held undisclosed acquisition offers from SLB at prices significantly higher than the then-current market price of ChampionX shares, the Company repurchased a sizable amount of its own common stock from unsuspecting investors at market prices significantly below those undisclosed offer prices. During the Class Period, ChampionX's average stock price was $33.32 per share. ChampionX had an obligation to disclose that it had received a formal acquisition offer from SLB or abstain from purchasing ChampionX stock from unsuspecting investors. On April 2, 2024, during pre-market hours, ChampionX disclosed the merger with SLB. The merger eventually closed on July 16, 2025, with SLB acquiring ChampionX for $40.58 per share. If you are a ChampionX investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267) 764-4865. About Berger Montague Berger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE. Andrew Abramowitz Berger Montague (215) 875-3015 [email protected] Caitlin Adorni Berger Montague (267) 764-4865 [email protected] (C) Newsfilecorp - 2026
INVESTOR ALERT: Pomerantz law Firm reminds investors with losses on their investment in ChampionX Corporation of class action lawsuit and upcoming deadlines - CHX. Jun 04, 2026, 10:00 ET NEW YORK, June 4, 2026 /PRNewswire/ - Pomerantz LLP announces that a class action lawsuit has been filed against ChampionX Corporation ("ChampionX" or the "Company") (NASDAQ: CHX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether ChampionX and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until July 14, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired ChampionX securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com. A Complaint has filed on behalf of investors who sold ChampionX common stock during the Class Period, alleging that the defendants failed to disclose material information, which artificially deflated the price of ChampionX common stock. Per the allegations of the Complaint, on February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The ChampionX class action lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. Danielle Peyton Pomerantz LLP 646-581-9980 ext. 7980 SOURCE Pomerantz LLP
Bronstein, Gewirtz & Grossman LLC urges ChampionX Corporation investors to act: Class Action filed alleging investor harm. Nationally recognized firm urges ChampionX Investors to explore Class Action representation. NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers. "Our practice focuses on restoring investor capital and ensuring corporate accountability to uphold market integrity," said Peretz Bronstein. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CHX. ChampionX Case Details The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) while repurchasing millions of dollars' worth of ChampionX Corporation ("ChampionX" or the "Company") common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited ("SLB") to acquire ChampionX at a premium to prevailing market prices; (2) Defendants failed to either abstain from trading or disclose SLB's offer(s), which, if disclosed, would have signaled to investors that ChampionX's stock was worth significantly more than its trading price; (3) Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times. What's Next for ChampionX Investors? A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CHX. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. No Cost to ChampionX Investors We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful. Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action? Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com "Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC. Contact Info Peretz Bronstein, Esq. or Nathan Miller Bronstein, Gewirtz & Grossman, LLC 917-590-0911 | [email protected] Attorney advertising. Prior results do not guarantee similar outcomes.
CHX investors have opportunity to lead ChampionX Corporation securities fraud lawsuit with the Schall Law Firm. May 19, 2026 21:22 ET | Source: Schall Law LOS ANGELES, May 19, 2026 (GLOBE NEWSWIRE) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChampionX Corporation ("ChampionX" or "the Company") (NASDAQ: CHX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 29, 2024 and April 1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 14, 2026. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected]. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. ChampionX purchased millions of dollars worth of its own shares while in possession of material nonpublic information about offers made by Schlumberger Limited ("SLB") to acquire it at a premium. The Company failed to disclose negotiations with SLB. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about ChampionX, investors suffered damages. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. The Schall Law Firm